Synopsys (SNPS)
(Delayed Data from NSDQ)
$561.55 USD
-12.04 (-2.10%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $561.71 +0.16 (0.03%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$561.55 USD
-12.04 (-2.10%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $561.71 +0.16 (0.03%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
Zacks News
Sapiens (SPNS) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Sapiens (SPNS) delivered earnings and revenue surprises of 2.86% and 0.46%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Synopsys (SNPS) Rises Higher Than Market: Key Facts
by Zacks Equity Research
Synopsys (SNPS) reachead $549.61 at the closing of the latest trading day, reflecting a +0.75% change compared to its last close.
Synopsys (SNPS) to Sell Software Integrity Business for $2.1B
by Zacks Equity Research
By divesting its Software Integrity Group, Synopsys (SNPS) seeks to optimize its operational efficiency and allocate resources more effectively.
Synopsys (SNPS) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Synopsys (SNPS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Investors Heavily Search Synopsys, Inc. (SNPS): Here is What You Need to Know
by Zacks Equity Research
Synopsys (SNPS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Synopsys (SNPS) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
Synopsys (SNPS) closed at $522.18 in the latest trading session, marking a -1.59% move from the prior day.
Commvault Systems (CVLT) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Commvault (CVLT) delivered earnings and revenue surprises of 8.22% and 4.83%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Synopsys (SNPS) Flat As Market Gains: What You Should Know
by Zacks Equity Research
Synopsys (SNPS) reachead $527.52 at the closing of the latest trading day, reflecting no change compared to its last close.
Here is What to Know Beyond Why Synopsys, Inc. (SNPS) is a Trending Stock
by Zacks Equity Research
Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Top Analyst Reports for Costco, NIKE & Fiserv
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corporation (COST), NIKE, Inc. (NKE) and Fiserv, Inc. (FI).
Garmin (GRMN) Expands European Footprint With Outdoor Maps+
by Zacks Equity Research
Garmin (GRMN) expands its Outdoor Maps+ offering to several European countries, boosting its adventure smartwatches portfolio.
Badger Meter (BMI) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Badger Meter's (BMI) first-quarter performance benefits from robust demand for smart water solutions.
Iridium (IRDM) Q1 Earnings Match Estimates, Revenues Down Y/Y
by Zacks Equity Research
Iridium's (IRDM) first-quarter performance benefits from solid momentum in commercial business lines.
Itron (ITRI) Gains 74% in a Year: Will the Trend Continue?
by Zacks Equity Research
Itron's (ITRI) performance benefits from strong operational execution and easing of supply-chain issues.
Cadence (CDNS) Unveils New Palladium Z3 Emulation System
by Zacks Equity Research
Cadence (CDNS) launches Palladium Z3 Emulation and Protium X3 FPGA Prototyping systems to advance SoC design.
Microchip (MCHP) Enhances Aviation Footprint With Latest Solution
by Zacks Equity Research
Microchip (MCHP) introduces an integrated actuation power solution for sustainable aviation, enhancing efficiency and reliability.
AMD Expands Portfolio With the Launch of Ryzen PRO Series
by Zacks Equity Research
AMD is expanding its footprint with the launch of the Ryzen PRO 8040 Series for mobile devices and the Ryzen PRO 8000 Series for desktops.
Garmin (GRMN) Solidifies Aviation Footprint Across Europe
by Zacks Equity Research
Garmin (GRMN) expands its Garmin Navigation Database coverage to Europe, bolstering its Aviation business.
America Movil's (AMX) Q1 Earnings & Revenues Decrease Y/Y
by Zacks Equity Research
America Movil's (AMX) first-quarter 2024 results are affected by softness in the Equipment business.
NetApp (NTAP) Up 51% in a Year: Will the Rally Continue?
by Zacks Equity Research
NetApp (NTAP) expects momentum in all-flash products, and hyper-scaler first-party and marketplace services to drive the top line amid uncertainty prevailing over macroeconomic conditions.
3D Systems' (DDD) Cranial Implant Solution Receives FDA Nod
by Zacks Equity Research
3D Systems (DDD) receives 510(k) clearance for its innovative 3D-printed, patient-specific cranial implant solution, the VSP PEEK Cranial Implant, from the FDA.
Guidewire (GWRE) Stock Rises 39.5% in a Year: Here's How
by Zacks Equity Research
Guidewire's (GWRE) performance gains from higher revenue growth across the subscription and support business segments.
Blackbaud (BLKB) Receives Buyout Offer From Clearlake Capital
by Zacks Equity Research
Blackbaud (BLKB) receives the buyout offer to acquire all the outstanding shares of the company for $80 per share from Clearlake Capital.
Generac (GNRC) Reportedly Focusing on M&A to Drive Growth
by Zacks Equity Research
Generac (GNRC) is looking at inorganic strategy to boost solutions portfolio and drive expansion, per a report from Bloomberg.
Cisco's (CSCO) Isovalent Buyout Expands Security Offering
by Zacks Equity Research
Cisco (CSCO) completes the previously announced acquisition of Isovalent, a leader in open-source cloud-native networking and security.